Tapewire

Nasdaq · USD

COLL

COLLEGIUM PHARMACEUTICAL, INC

Export transactions ↓
Tapewire entity
5169
SEC CIK
0001267565
Parsed reports
359

Last 12 months

Inside the activity.

0 purchase rows · 14 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202503
Jan 202600
Feb 202600
Mar 202604
Apr 202600
May 202604
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 10, 2022 Filed Feb 14, 2022 18:37 UTC
Kuhlmann Shirley R.EVP and General Counsel
Tax withholdingCommon Stock 6,967 $17.63 $122,828.21
Disclosure

SEC source: 0001062993-22-004319 · form4.xml · nonDerivative · entry 3

Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,330

F3 · shares: Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 18:37 UTC
Kuhlmann Shirley R.EVP and General Counsel
GrantCommon Stock 14,341 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-22-004319 · form4.xml · nonDerivative · entry 2

Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,297

F2 · price: On February 10, 2022, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 14,341 performance share units granted in the issuer's three prior fiscal years.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 18:37 UTC
Kuhlmann Shirley R.EVP and General Counsel
GrantCommon Stock 56,700 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-004319 · form4.xml · nonDerivative · entry 1

Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,956

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2023, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 23:37 UTC
Ciaffoni JosephDirector · President and CEO
Tax withholdingCommon Stock 28,843 $17.63 $508,502.09
Disclosure

SEC source: 0001062993-22-004320 · form4.xml · nonDerivative · entry 4

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400,941

F4 · shares: Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 23:37 UTC
Ciaffoni JosephDirector · President and CEO
Tax withholdingCommon Stock 24,154 $17.63 $425,835.02
Disclosure

SEC source: 0001062993-22-004320 · form4.xml · nonDerivative · entry 3

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 429,784

F3 · shares: Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 23:37 UTC
Ciaffoni JosephDirector · President and CEO
GrantCommon Stock 65,034 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-22-004320 · form4.xml · nonDerivative · entry 2

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 453,938

F2 · price: On February 10, 2022, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 65,034 performance share units granted in the issuer's three prior fiscal years.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 23:37 UTC
Ciaffoni JosephDirector · President and CEO
GrantCommon Stock 125,000 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-004320 · form4.xml · nonDerivative · entry 1

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 388,904

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2023, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 23:49 UTC
Malamut RichardEVP and Chief Medical Officer
Tax withholdingCommon Stock 1,838 $17.63 $32,403.94
Disclosure

SEC source: 0001062993-22-004326 · form4.xml · nonDerivative · entry 4

Malamut Richard · CIK 0001772168 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,264

F4 · shares: Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 23:49 UTC
Malamut RichardEVP and Chief Medical Officer
Tax withholdingCommon Stock 4,462 $17.63 $78,665.06
Disclosure

SEC source: 0001062993-22-004326 · form4.xml · nonDerivative · entry 3

Malamut Richard · CIK 0001772168 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,102

F3 · shares: Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 23:49 UTC
Malamut RichardEVP and Chief Medical Officer
GrantCommon Stock 6,256 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-22-004326 · form4.xml · nonDerivative · entry 2

Malamut Richard · CIK 0001772168 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,564

F2 · price: On February 10, 2022, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 6,256 performance share units granted in the issuer's two prior fiscal years.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 23:49 UTC
Malamut RichardEVP and Chief Medical Officer
GrantCommon Stock 36,750 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-004326 · form4.xml · nonDerivative · entry 1

Malamut Richard · CIK 0001772168 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,308

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2023, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 23:36 UTC
Dreyer ScottEVP & Chief Commercial Officer
Tax withholdingCommon Stock 4,016 $17.63 $70,802.08
Disclosure

SEC source: 0001062993-22-004318 · form4.xml · nonDerivative · entry 4

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,785

F4 · shares: Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 23:36 UTC
Dreyer ScottEVP & Chief Commercial Officer
Tax withholdingCommon Stock 6,643 $17.63 $117,116.09
Disclosure

SEC source: 0001062993-22-004318 · form4.xml · nonDerivative · entry 3

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,801

F3 · shares: Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 23:36 UTC
Dreyer ScottEVP & Chief Commercial Officer
GrantCommon Stock 13,675 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-22-004318 · form4.xml · nonDerivative · entry 2

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,444

F2 · price: On February 10, 2022, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 13,675 performance share units granted in the issuer's three prior fiscal years.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 23:36 UTC
Dreyer ScottEVP & Chief Commercial Officer
GrantCommon Stock 52,500 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-004318 · form4.xml · nonDerivative · entry 1

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,769

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2023, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.

Read SEC document
February 10, 2022 Filed Mar 3, 2022 16:13 UTC Amendment
Tupper ColleenEVP & Chief Financial Officer
Tax withholdingCommon Stock 1,237 $17.63 $21,808.31
Disclosure

SEC source: 0001062993-22-006643 · form4a.xml · nonDerivative · entry 4

Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,654

F4 · shares: Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units.

Read SEC document
February 10, 2022 Filed Mar 3, 2022 16:13 UTC Amendment
Tupper ColleenEVP & Chief Financial Officer
Tax withholdingCommon Stock 2,821 $17.63 $49,734.23
Disclosure

SEC source: 0001062993-22-006643 · form4a.xml · nonDerivative · entry 3

Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,891

F3 · shares: Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
February 10, 2022 Filed Mar 3, 2022 16:13 UTC Amendment
Tupper ColleenEVP & Chief Financial Officer
GrantCommon Stock 4,212 Not disclosed Not disclosed
Disclosure

SEC source: 0001062993-22-006643 · form4a.xml · nonDerivative · entry 2

Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,712

F2 · price: On February 10, 2022, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 4,212 performance share units granted in the issuer's prior fiscal year.

Read SEC document
February 10, 2022 Filed Mar 3, 2022 16:13 UTC Amendment
Tupper ColleenEVP & Chief Financial Officer
GrantCommon Stock 52,500 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-006643 · form4a.xml · nonDerivative · entry 1

Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,500

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2023, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.

Read SEC document
January 10, 2022 Filed Jan 12, 2022 21:22 UTC
Dreyer ScottEVP & Chief Commercial Officer
Tax withholdingCommon Stock 701 $19.05 $13,354.05
Disclosure

SEC source: 0001879789-22-000002 · primary_doc.xml · nonDerivative · entry 1

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,269

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 21:06 UTC
Ciaffoni JosephDirector · President and CEO
Tax withholdingCommon Stock 1,090 $18.68 $20,361.20
Disclosure

SEC source: 0001879789-22-000001 · primary_doc.xml · nonDerivative · entry 1

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 263,904

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
December 15, 2021 Filed Dec 17, 2021 21:33 UTC
Dreyer ScottEVP & Chief Commercial Officer
SaleCommon Stock 5,693 $18.33 $104,352.69
Disclosure

SEC source: 0001879789-21-000022 · primary_doc.xml · nonDerivative · entry 1

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,970

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2021 and amended on September 1, 2021.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.95 to $18.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).

Read SEC document
September 16, 2021 Filed Sep 20, 2021 16:03 UTC
Kuhlmann Shirley R.EVP and General Counsel
Tax withholdingCommon Stock 734 $19.67 $14,437.78
Disclosure

SEC source: 0001879789-21-000003 · edgar.xml · nonDerivative · entry 1

Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,256

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
August 10, 2021 Filed Aug 12, 2021 16:03 UTC
Fleming Alison BEVP & Chief Technical Officer
Tax withholdingCommon Stock 1,386 $19.03 $26,375.58
Disclosure

SEC source: 0001192482-21-000662 · edgar.xml · nonDerivative · entry 1

Fleming Alison B · CIK 0001640701 · EVP & Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,694

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
August 10, 2021 Filed Aug 12, 2021 20:01 UTC
Ciaffoni JosephDirector · President and CEO
Tax withholdingCommon Stock 1,386 $19.03 $26,375.58
Disclosure

SEC source: 0001192482-21-000661 · edgar.xml · nonDerivative · entry 1

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 264,994

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
July 12, 2021 Filed Jul 14, 2021 20:17 UTC
Dreyer ScottEVP & Chief Commercial Officer
Tax withholdingCommon Stock 595 $23.17 $13,786.15
Disclosure

SEC source: 0001104659-21-092117 · tm2122232-1_4seq1.xml · nonDerivative · entry 1

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,663

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 20:03 UTC
Ciaffoni JosephDirector · President and CEO
Tax withholdingCommon Stock 1,394 $23.99 $33,442.06
Disclosure

SEC source: 0001192482-21-000623 · edgar.xml · nonDerivative · entry 1

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 266,380

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
June 02, 2021 Filed Jun 3, 2021 20:16 UTC
Ciaffoni JosephDirector · President and CEO
SaleCommon Stock 5,861 $22.81 $133,689.41
Disclosure

SEC source: 0001192482-21-000479 · edgar.xml · nonDerivative · entry 5

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,774

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2020.

Read SEC document
June 01, 2021 Filed Jun 3, 2021 20:16 UTC
Ciaffoni JosephDirector · President and CEO
Exercise / conversionStock Option (Right to Purchase) · Derivative 16,205 $0.00 Strike: $8.22 $0.00
Disclosure

SEC source: 0001192482-21-000479 · edgar.xml · derivative · entry 6

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,205 shares

Expires 2027-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: All of the 16,205 option shares are exercisable.

Read SEC document
June 01, 2021 Filed Jun 3, 2021 20:16 UTC
Ciaffoni JosephDirector · President and CEO
SaleCommon Stock 10,829 $23.33 $252,640.57
Disclosure

SEC source: 0001192482-21-000479 · edgar.xml · nonDerivative · entry 4

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 273,635

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2020.

F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.88, inclusive.

Read SEC document
June 01, 2021 Filed Jun 3, 2021 20:16 UTC
Ciaffoni JosephDirector · President and CEO
SaleCommon Stock 5,376 $22.93 $123,271.68
Disclosure

SEC source: 0001192482-21-000479 · edgar.xml · nonDerivative · entry 3

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 284,464

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2020.

F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.79 to $22.99, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (3) and (4).

Read SEC document
June 01, 2021 Filed Jun 3, 2021 20:16 UTC
Ciaffoni JosephDirector · President and CEO
Exercise / conversionCommon Stock 16,205 $8.22 $133,205.10
Disclosure

SEC source: 0001192482-21-000479 · edgar.xml · nonDerivative · entry 2

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 289,840

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 01, 2021 Filed Jun 3, 2021 20:16 UTC
Ciaffoni JosephDirector · President and CEO
Tax withholdingCommon Stock 4,672 $22.90 $106,988.80
Disclosure

SEC source: 0001192482-21-000479 · edgar.xml · nonDerivative · entry 1

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 273,635

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
May 24, 2021 Filed May 24, 2021 17:11 UTC
Tupper ColleenEVP & Chief Financial Officer
GrantCommon Stock 42,000 $0.00 $0.00
Disclosure

SEC source: 0001192482-21-000452 · edgar.xml · nonDerivative · entry 1

Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,000

F1 · security: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2022, and the balance of the restricted stock units vest in equal annual installments (in each case, rounded up to the nearest whole share of common stock) over the following three year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.

Read SEC document
May 20, 2021 Filed May 24, 2021 21:19 UTC GrantCommon Stock 9,941 $0.00 $0.00
Disclosure

SEC source: 0001192482-21-000456 · edgar.xml · nonDerivative · entry 1

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,988

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 20, 2022, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.

Read SEC document
May 20, 2021 Filed May 24, 2021 21:34 UTC GrantCommon Stock 9,941 $0.00 $0.00
Disclosure

SEC source: 0001192482-21-000460 · edgar.xml · nonDerivative · entry 1

Freund John Gordon · CIK 0001296771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,948

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 20, 2022, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.

Read SEC document
May 20, 2021 Filed May 24, 2021 21:18 UTC
SANTINI GINODirector
GrantCommon Stock 9,941 $0.00 $0.00
Disclosure

SEC source: 0001192482-21-000455 · edgar.xml · nonDerivative · entry 1

SANTINI GINO · CIK 0001276038 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,136

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 20, 2022, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.

Read SEC document
May 20, 2021 Filed May 24, 2021 21:20 UTC GrantCommon Stock 9,941 $0.00 $0.00
Disclosure

SEC source: 0001192482-21-000457 · edgar.xml · nonDerivative · entry 1

Fallon John A. · CIK 0001560152 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,323

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 20, 2022, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.

Read SEC document
May 20, 2021 Filed May 24, 2021 21:22 UTC GrantCommon Stock 9,941 $0.00 $0.00
Disclosure

SEC source: 0001192482-21-000458 · edgar.xml · nonDerivative · entry 1

Balice-Gordon Rita J. · CIK 0001825625 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,968

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 20, 2022, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.

Read SEC document
May 20, 2021 Filed May 24, 2021 21:14 UTC GrantCommon Stock 9,941 $0.00 $0.00
Disclosure

SEC source: 0001192482-21-000453 · edgar.xml · nonDerivative · entry 1

BOHLIN GAREN G · CIK 0001254705 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,948

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 20, 2022, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.

Read SEC document
May 20, 2021 Filed May 24, 2021 21:16 UTC GrantCommon Stock 9,941 $0.00 $0.00
Disclosure

SEC source: 0001192482-21-000454 · edgar.xml · nonDerivative · entry 1

Melincoff Gwen A · CIK 0001614890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,948

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 20, 2022, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.

Read SEC document
May 10, 2021 Filed May 12, 2021 16:06 UTC
Kuhlmann Shirley R.EVP and General Counsel
SaleCommon Stock 7,000 $22.77 $159,390.00
Disclosure

SEC source: 0001192482-21-000419 · edgar.xml · nonDerivative · entry 1

Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,990

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 18:54 UTC
Fleming Alison BEVP & Chief Technical Officer
Tax withholdingCommon Stock 7,900 $23.38 $184,702.00
Disclosure

SEC source: 0001192482-21-000309 · edgar.xml · nonDerivative · entry 2

Fleming Alison B · CIK 0001640701 · EVP & Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,080

F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 18:54 UTC
Fleming Alison BEVP & Chief Technical Officer
Tax withholdingCommon Stock 1,757 $23.38 $41,078.66
Disclosure

SEC source: 0001192482-21-000309 · edgar.xml · nonDerivative · entry 1

Fleming Alison B · CIK 0001640701 · EVP & Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,980

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of performance stock units.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 23:07 UTC
Malamut RichardEVP and Chief Medical Officer
Tax withholdingCommon Stock 3,119 $23.38 $72,922.22
Disclosure

SEC source: 0001192482-21-000322 · edgar.xml · nonDerivative · entry 1

Malamut Richard · CIK 0001772168 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,558

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
March 30, 2021 Filed Apr 1, 2021 16:14 UTC
Fleming Alison BChief Technical Officer
GrantCommon Stock 5,984 Not disclosed Not disclosed
Disclosure

SEC source: 0001192482-21-000288 · edgar.xml · nonDerivative · entry 1

Fleming Alison B · CIK 0001640701 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,737

F1 · price: On March 30, 2021, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to 5,984 performance share units granted on February 5, 2020.

Read SEC document
March 16, 2021 Filed Mar 18, 2021 16:07 UTC
Kuhlmann Shirley R.EVP and General Counsel
Tax withholdingCommon Stock 734 $24.69 $18,122.46
Disclosure

SEC source: 0001192482-21-000251 · edgar.xml · nonDerivative · entry 1

Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,990

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
March 15, 2021 Filed Mar 17, 2021 20:03 UTC SaleCommon Stock 3,031 $25.88 $78,442.28
Disclosure

SEC source: 0001192482-21-000248 · edgar.xml · nonDerivative · entry 2

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,047

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.

F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.83 to $26.03, inclusive.

Read SEC document
March 15, 2021 Filed Mar 17, 2021 20:03 UTC SaleCommon Stock 47,044 $25.26 $1,188,331.44
Disclosure

SEC source: 0001192482-21-000248 · edgar.xml · nonDerivative · entry 1

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,078

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.83 to $25.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

Read SEC document
March 01, 2021 Filed Mar 3, 2021 20:01 UTC
Fleming Alison BChief Technical Officer
SaleCommon Stock 6,011 $23.36 $140,416.96
Disclosure

SEC source: 0001192482-21-000211 · edgar.xml · nonDerivative · entry 12

Fleming Alison B · CIK 0001640701 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,753

F4 · kind: The sale reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2020.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.